Biopharmaceutical research and innovation by Oric Pharmaceuticals

  • Emilio Ghigini
  • 02.06.2026
Oric Pharmaceuticals stock under sustained selling pressure, trades near new support zone
Oric Pharmaceuticals said President and CEO Jacob Chacko and CFO Dom Piscitelli will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 11:40 a.m. ...
  • Igor Krasulya
  • 18.03.2026
Oric Pharmaceuticals to present rinzimetostat data at AACR2026
Oric Pharmaceuticals announced that two preclinical abstracts detailing the potential of rinzimetostat (ORIC-944) for prostate cancer treatment have been accepted for poster presentation at the ...
  • Hanna Syniavska
  • 11.03.2026
Oric Pharmaceuticals celebrates Employee Appreciation Day with recognition initiatives
Oric Pharmaceuticals launched a series of activities to honor Employee Appreciation Day, recognizing the contributions of its team members. The company emphasized wellness initiatives, ...